Funded Tech Companies
Achillion Pharmaceuticals
Researching who provided funding to Achillion Pharmaceuticals? Advent International, Societe Generale and SV Health Investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Achillion Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1777 Sentry Pkwy. West VEVA Building #14 200
Blue Bell, PA 19422
USA
Blue Bell, PA 19422
USA
Phone
Website
Email Address
Company Background Information
Overview
Achillion is a science-driven, patient-focused company with the goal of providing better treatments for people with serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2006
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Truitt
Chief Financial Officer
Brian Di Donato
Chief Medical Officer
Steven Zelenkofske
Chief Operating Officer
Paul Firuta
Vice President
Susanne Heinzinger
VP - Bus. Development
Michael Geffner
VP - Bus. Development
Anthony Gibney
VP - General Counsel
Martha Manning
VP - Human Resources
Ky Nam-Wortman
VP - R & D
Mingjun Huang
VP - Regulatory Affairs
Kevin Malobisky
Company Investors
- Advent International (Jason Fisherman)
- Societe Generale
- SV Health Investors
- Bear Stearns Health Innoventures (Stefan Ryser)
- Connecticut Innovations
- Oak Investment Partners
- Atlas Venture (Jean-Francois Formela)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs